SMAD1 and pulmonary arterial hypertension: On protein level, short-term BMP9 treatment induced a significant activation of BMP-dependent signaling by phosphorylation of SMAD1 (p ≤ 0.001) that was similar in controls and PAH MVECs (Fig. 1c).